01:44 PM EDT, 05/14/2025 (MT Newswires) -- Incannex Healthcare ( IXHL ) said Wednesday it completed patient dosing in the phase 2 portion of its phase 2/3 study of IHL-42X in obstructive sleep apnea. The company also said it expects to conclude end-of-study follow-up assessments by May 17, with topline data anticipated in July.

Shares surged 793% as intraday trading volume soared to over 1.24 billion from a daily average of about 1.16 million.

Antalpha Platform's ( ANTA ) shares surged 68% in their debut on Nasdaq Wednesday after the company priced its initial public offering of 3.85 million shares at $12.80 each.

More than 4.22 million shares of the company traded intraday.

Bluebird bio (BLUE), Carlyle (CG), and SK Capital Partners said Wednesday they have amended their Bluebird acquisition agreement to give shareholders a new cash option of $5 a share.

Shares of Bluebird catapulted 50% as intraday trading volume advanced to more than 8.45 million from a daily average of about 467,000.

Price: 0.76, Change: +0.68, Percent Change: +793.08